Stratis Group

Stratis Group is a U. S. -based strategic consulting firm specializing in the commercialization lifecycle within the pharmaceutical and healthcare sectors, providing key insights and support for product growth and market entry. Founded in 2012 and headquartered in New York, US, Stratis Group focuses on consulting services primarily for the pharmaceutical and healthcare industries.

The company has engaged in one deal, with its most recent transaction occurring on March 17, 2026, when Nexus Health Group acquired Stratis Group to enhance its consulting support and market access capabilities. The details of the financial terms remain undisclosed. Stratis provides a comprehensive suite of strategic consulting services tailored to the commercialization lifecycle, focusing on the pharmaceutical and healthcare sectors. Their core offerings include early commercialization support, market access strategies, brand analytics, and patient support services, designed to help clients navigate the complexities of product growth and market entry.

Stratis aims to enhance product positioning, sustain relevance in competitive markets, and identify new growth opportunities by leveraging data-driven insights and rigorous research methodologies. Their solutions cater to a diverse clientele, including pharmaceutical companies, healthcare providers, and organizations seeking to optimize their product lifecycles, primarily serving markets in North America and Europe. The end users of Stratis's services are often patients, healthcare professionals, and stakeholders involved in the healthcare continuum, each benefiting from improved product accessibility and market strategies. Stratis's revenue model is primarily based on consulting fees charged for its specialized services across various stages of the commercialization process.

Clients engage with Stratis through partnerships and contractual agreements that outline specific deliverables related to market entry, product positioning, and ongoing support. The structure of these transactions typically involves customized consulting packages tailored to the unique needs of each client, which may include subscriptions for ongoing market analysis and analytics-driven insights. While specific pricing details for individual services are not disclosed, engagement models are designed to ensure that clients receive comprehensive support throughout their product's journey, from pre-launch strategies to market adoption and beyond. The company's revenue generation is closely tied to its ability to deliver impactful results that drive client success in the evolving healthcare landscape.

Stratis Group is positioned for future growth following its acquisition by Nexus Health Group in March 2026. The acquisition aims to enhance Stratis's consulting support and market access capabilities. Although specific upcoming products have not been disclosed, the integration is expected to expand Stratis's reach and operational scope. There are plans for Stratis to target new markets and geographic regions, although specific details regarding those markets are currently not available.